VIVK ends the month with more than a double on Friday!
This is the highest volume VIVK has ever seen! Investors were grabbing any and all shares available all day as the stock got continuously assaulted with buy orders!
VIVK is the hottest biotech play on Wall Street!
VIVK finished higher than any stock on either the AMEX, NASDAQ, or NYSE!
All weekend people will continue to hear about VIVK and when they do, they will see the news that came out just in the last hour before close and look to bid VIVK much higher next week!
VIVK announced that in addition to its earlier PR projection of $20 million in annual revenues for its VivaThermic division, VivaThermic products have found new markets that include gene amplification applications and similar uses where temperature control is especially critical. These new market opportunities for VIVK are huge since Thermo-cycling and other temperature sensitive reactions have become common in nearly every biological laboratory!
VIVK is fast becoming a must-have addition to one's biotech portfolio, and you must pay attention before this stock doubles again and well beyond!
About Vivakor:
Vivakor, Inc. (“Vivakor,” the “Company,” or “we”) is a transdisciplinary research company that develops products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds. We also provide contract research services for third parties. We have developed numerous products and have filed many patents or provisional patents with the United States Patent and Trademark Office (USPTO). We intend to commercialize such products, after completion of any required regulatory approvals, through one of three methods: a sale of the technology, licensing of the product to a manufacturer or distributor or, in some cases, by manufacturing, marketing and directly selling the products ourselves.
For more information about Vivakor, please visit OTCMB Featured Company page: http://otcmarketbulls.com/featured-company/vivakor-inc.html
No comments:
Post a Comment